Targeted glycemic reduction in critical care using closed-loop control

Diabetes Technology and Therapeutics

Volumn 7, Issue 2, 2005, Pages 274-282

  Chase, J Geoffrey ^a,b,c   Shaw, Geoffrey M ^d   Lin, Jessica ^a   Doran, Carmen V ^a   Hann, Chris ^a   Lotz, Thomas ^a   Wake, Graeme C ^b   Broughton, Bob ^b  

^a Department of Mechanical Engineering   (New Zealand)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARTMENT MODEL; CRITICAL ILLNESS; FEMALE; GLUCOSE HOMEOSTASIS; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; MALE; MEDICAL ETHICS; ORGANIZATION; PARAMETER; PHYSIOLOGY; PRIORITY JOURNAL;

AGED; ALGORITHMS; AORTIC ANEURYSM, ABDOMINAL; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CRITICAL CARE; DIABETES MELLITUS, TYPE 2; FEMALE; HALF-LIFE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 17844409621     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.274     Document Type: Article

References (28)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773-778.
2. Coursin DB, Murray MJ: How sweet is euglycemia in critically ill patients? Mayo Clin Proc 2003;78:1460-1462.
3. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478.
4. Krinsley JS: Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol [abstract]. Crit Care Med 2003;31:A19.
5. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001;17:107-124.
6. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
7. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.
8. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH: Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol 2002;282:E992-E1007.
9. Chee F, Fernando T, van Heerden PV: Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care 2002;30:295-307.
10. Doran CV, Chase JG, Shaw GM, Moorhead KT, Hudson NH: Automated insulin infusion trials in the intensive care unit. Diabetes Technol Ther 2004;6:155-165.
11. Steil GM, Panteleon AE, Rebrin K: Closed-loop insulin delivery - the path to physiological glucose control. Adv Drug Deliv Rev 2004;56:125-144.
12. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR: Closing the loop: The Adicol experience. Diabetes Technol Ther 2004;6:307-318.
13. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
14. Natali A, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Masoni A, Ferrannini E, Mari A: Dose-response characteristics of insulin action on glucose metabolism: A non-steady-state approach. Am J Physiol 2000;278:E794-E801.
15. Prigeon RL, Roder ME, Porte D Jr, Kahn SE: The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest 1996;97:501-507.
16. Thorsteinsson B: Kinetic models for insulin disappearance from plasma in man. Dan Med Bull 1990;37:143-153.
17. Ellemann K, Thorsteinsson B, Fugleberg S, Feldt-Rasmussen B, Andersen OO, Gronbaek P, Binder C: Kinetics of insulin disappearance from plasma in cortisone-treated normal subjects. Clin Endocrinol (Oxf) 1987;26:623-628.
18. Caumo A, Vicini P, Zachwieja JJ, Avogaro A, Yarasheski K, Bier DM, Cobelli C: Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol 1999;276:E1171-E1193.
19. Bettini F, Caumo A, Cobelli C: Minimal models in meal-like protocols: Simulation studies to assess precision and physiological plausibility of parameter estimates. In: IEEE 17th Annual Conference. New York: IEEE, 1995:1361-1362.
20. Arkray Inc.: Glucocard™ Test Strip 2 Data Sheet. In: Glucocard™ Test Strip 2 Data Sheet. Kyoto: Arkray Inc., 2001.
21. Hann CE, Hickman MS: Projective curvature and integral invariants. Acta Appl Math 2002;74:177-193.
22. Hovorka R, Vicini P: Parameter estimation. In: Carson E, Cobelli C, eds. Modelling Methodology for Physiology and Medicine. London: Academic Press, 2001:107-151.
23. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
24. Cobelli C, Caumo A, Omenetto M: Minimal model SG overestimation and SI underestimation: Improved accuracy by a Bayesian two-compartment model. Am J Physiol 1999;277:E481-E488.
25. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
26. Lin J, Chase JG, Shaw GM, Doran CV, Hann CE, Robertson MB, Browne PM, Lotz TF, Wake GC, Broughton B: Adaptive bolus-based set-point regulation of hyperglycemia in critical care. In: Proceedings of the 26th International Conference of IEEE Engineering in Medicine and Biology (EMBS 2004), San Francisco, CA, Sept 1-5. New York: IEEE, 2004:3463-3466.
27. Lin J, Chase JG, Shaw GM, Lotz TF, Hann CE, Doran CV, Lee DS: Long term verification of glucose-insulin regulatory system model dynamics. In: Proceedings of the 26th International Conference of IEEE Engineering in Medicine and Biology (EMBS 2004), San Francisco, CA, Sept 1-5. New York: IEEE, 2004:758-761.
28. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE: Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004;6:339-347.